{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:37:58Z","timestamp":1791959878256,"version":"4.3.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00401-012-1035-z","type":"journal-article","created":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T13:10:41Z","timestamp":1346505041000},"page":"733-747","source":"Crossref","is-referenced-by-count":131,"title":["Co-aggregation of RNA binding proteins in ALS spinal motor neurons: evidence of a common pathogenic mechanism"],"prefix":"10.1007","volume":"124","author":[{"given":"Brian A.","family":"Keller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Volkening","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian A.","family":"Droppelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee Cyn","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Rademakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Strong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,1]]},"reference":[{"key":"1035_CR1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00401-011-0911-2","volume":"122","author":"S Al-Sarraj","year":"2011","unstructured":"Al-Sarraj S, King A, Troakes C et al (2011) p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND\/ALS. Acta Neuropathol 122:691\u2013702","journal-title":"Acta Neuropathol"},{"key":"1035_CR2","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai T, Hasegawa M, Akiyama H et al (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351:602\u2013611","journal-title":"Biochem Biophys Res Commun"},{"key":"1035_CR3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00005072-199405000-00002","volume":"53","author":"C Bergeron","year":"1994","unstructured":"Bergeron C, Beric-Maskarel K, Muntasser S et al (1994) Neurofilament light and polyadenylated mRNA levels are decreased in amyotrophic lateral sclerosis motor neurons. J Neuropathol Exp Neurol 53:221\u2013230","journal-title":"J Neuropathol Exp Neurol"},{"key":"1035_CR4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/brain\/aws004","volume":"135","author":"BF Boeve","year":"2012","unstructured":"Boeve BF, Boylan KB, Graff-Radford NR et al (2012) Characterization of frontotemporal dementia and\/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain 135:765\u2013783","journal-title":"Brain"},{"key":"1035_CR5","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/nn.2660","volume":"13","author":"DA Bosco","year":"2010","unstructured":"Bosco DA, Morfini G, Karabacak NM et al (2010) Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci 13:1396\u20131403","journal-title":"Nat Neurosci"},{"key":"1035_CR6","doi-asserted-by":"crossref","first-page":"32046","DOI":"10.1074\/jbc.M104104200","volume":"276","author":"R Canete-Soler","year":"2001","unstructured":"Canete-Soler R, Wu J, Zhai J, Shamim M, Schlaepfer WW (2001) p190RhoGEF Binds to a destabilizing element in the 3\u2032 untranslated region of light neurofilament subunit mRNA and alters the stability of the transcript. J Biol Chem 276:32046\u201332050","journal-title":"J Biol Chem"},{"key":"1035_CR7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1212\/WNL.18.9.841","volume":"18","author":"S Carpenter","year":"1968","unstructured":"Carpenter S (1968) Proximal axonal enlargement in motor neuron disease. Neurology 18:841\u2013851","journal-title":"Neurology"},{"key":"1035_CR8","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/421054","volume":"74","author":"YZ Chen","year":"2004","unstructured":"Chen YZ, Bennett CL, Huynh HM et al (2004) DNA\/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet 74:1128\u20131135","journal-title":"Am J Hum Genet"},{"key":"1035_CR9","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/brain\/awr366","volume":"135","author":"A Chio","year":"2012","unstructured":"Chio A, Borghero G, Restagno G et al (2012) Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. Brain 135:784\u2013793","journal-title":"Brain"},{"key":"1035_CR10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/brain\/awr365","volume":"135","author":"J Cooper-Knock","year":"2012","unstructured":"Cooper-Knock J, Hewitt C, Highley JR et al (2012) Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain 135:751\u2013764","journal-title":"Brain"},{"key":"1035_CR11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez M, Mackenzie IR, Boeve BF et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245\u2013256","journal-title":"Neuron"},{"key":"1035_CR12","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archneurol.2011.178","volume":"68","author":"HX Deng","year":"2011","unstructured":"Deng HX, Bigio EH, Zhai H et al (2011) Differential involvement of optineurin in amyotrophic lateral sclerosis with or without SOD1 mutations. Arch Neurol 68:1057\u20131061","journal-title":"Arch Neurol"},{"key":"1035_CR13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nature10353","volume":"477","author":"HX Deng","year":"2011","unstructured":"Deng HX, Chen W, Hong ST et al (2011) Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS\/dementia. Nature 477:211\u2013215","journal-title":"Nature"},{"key":"1035_CR14","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archneurol.2010.101","volume":"67","author":"HX Deng","year":"2010","unstructured":"Deng HX, Zhai H, Bigio EH et al (2010) FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann Neurol 67:739\u2013748","journal-title":"Ann Neurol"},{"key":"1035_CR15","author":"CA Droppelmann","year":"2012","unstructured":"Droppelmann CA, Keller BA, Campos-Melo D, Volkening K, Strong MJ (2012) Rho guanine nucleotide exchange factor is a NFL mRNA destabilizing factor that forms cytoplasmic inclusions in amyotrophic lateral sclerosis. Neurobiol Aging. doi: 10\/1016\/jneurobiolaging.2012.06.021","journal-title":"Neurobiol Aging"},{"key":"1035_CR16","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature09320","volume":"466","author":"AC Elden","year":"2010","unstructured":"Elden AC, Kim HJ, Hart MP et al (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466:1069\u20131075","journal-title":"Nature"},{"key":"1035_CR17","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1111\/j.1742-4658.2011.08258.x","volume":"278","author":"FC Fiesel","year":"2011","unstructured":"Fiesel FC, Kahle PJ (2011) TDP-43 and FUS\/TLS: cellular functions and implications for neurodegeneration. FEBS J 278:3550\u20133568","journal-title":"FEBS J"},{"key":"1035_CR18","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00401-011-0805-3","volume":"121","author":"K Forsberg","year":"2011","unstructured":"Forsberg K, Andersen PM, Marklund SL, Brannstrom T (2011) Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis. Acta Neuropathol 121:623\u2013634","journal-title":"Acta Neuropathol"},{"key":"1035_CR19","doi-asserted-by":"crossref","first-page":"e11552","DOI":"10.1371\/journal.pone.0011552","volume":"5","author":"K Forsberg","year":"2010","unstructured":"Forsberg K, Jonsson PA, Andersen PM et al (2010) Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS ONE 5:e11552","journal-title":"PLoS ONE"},{"key":"1035_CR20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1074\/jbc.M405065200","volume":"280","author":"WW Ge","year":"2005","unstructured":"Ge WW, Wen W, Strong W, Leystra-Lantz C, Strong MJ (2005) Mutant copper-zinc superoxide dismutase binds to and destabilizes human low molecular weight neurofilament mRNA. J Biol Chem 280:118\u2013124","journal-title":"J Biol Chem"},{"key":"1035_CR21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.pneurobio.2011.08.011","volume":"95","author":"F Geser","year":"2011","unstructured":"Geser F, Prvulovic D, O\u2019Dwyer L et al (2011) On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia. Prog Neurobiol 95:649\u2013662","journal-title":"Prog Neurobiol"},{"key":"1035_CR22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ng1742","volume":"38","author":"MJ Greenway","year":"2006","unstructured":"Greenway MJ, Andersen PM, Russ C et al (2006) ANG mutations segregate with familial and \u2018sporadic\u2019 amyotrophic lateral sclerosis. Nat Genet 38:411\u2013413","journal-title":"Nat Genet"},{"key":"1035_CR23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00401-011-0813-3","volume":"121","author":"T Hortobagyi","year":"2011","unstructured":"Hortobagyi T, Troakes C, Nishimura AL et al (2011) Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders. Acta Neuropathol 121:519\u2013527","journal-title":"Acta Neuropathol"},{"key":"1035_CR24","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00401-011-0913-0","volume":"122","author":"PG Ince","year":"2011","unstructured":"Ince PG, Highley JR, Kirby J et al (2011) Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology. Acta Neuropathol 122:657\u2013671","journal-title":"Acta Neuropathol"},{"key":"1035_CR25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00401-011-0809-z","volume":"121","author":"H Ito","year":"2011","unstructured":"Ito H, Fujita K, Nakamura M et al (2011) Optineurin is co-localized with FUS in basophilic inclusions of ALS with FUS mutation and in basophilic inclusion body disease. Acta Neuropathol 121:555\u2013557","journal-title":"Acta Neuropathol"},{"key":"1035_CR26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/17482968.2012.686511","volume":"13","author":"E Kabashi","year":"2012","unstructured":"Kabashi E, Agar JN, Strong MJ, Durham HD (2012) Impaired proteasome function in sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler 13:367\u2013371","journal-title":"Amyotroph Lateral Scler"},{"key":"1035_CR27","first-page":"973","volume":"14","author":"S Kato","year":"1999","unstructured":"Kato S, Saito M, Hirano A, Ohama E (1999) Recent advances in research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutations: neuronal Lewy body-like hyaline inclusions and astrocytic hyaline inclusions. Histol Histopathol 14:973\u2013989","journal-title":"Histol Histopathol"},{"key":"1035_CR28","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.1166066","volume":"323","author":"TJ Kwiatkowski Jr","year":"2009","unstructured":"Kwiatkowski TJ Jr, Bosco DA, Leclerc AL et al (2009) Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323:1205\u20131208","journal-title":"Science"},{"key":"1035_CR29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00401-007-0226-5","volume":"114","author":"LK Kwong","year":"2007","unstructured":"Kwong LK, Neumann M, Sampathu DM, Lee VM, Trojanowski JQ (2007) TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease. Acta Neuropathol 114:63\u201370","journal-title":"Acta Neuropathol"},{"key":"1035_CR30","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1093\/hmg\/ddq137","volume":"19","author":"C Lagier-Tourenne","year":"2010","unstructured":"Lagier-Tourenne C, Polymenidou M, Cleveland DW (2010) TDP-43 and FUS\/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet 19:R46\u2013R64","journal-title":"Hum Mol Genet"},{"key":"1035_CR31","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/hmg\/ddr045","volume":"20","author":"T Lee","year":"2011","unstructured":"Lee T, Li YR, Ingre C et al (2011) Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients. Hum Mol Genet 20:1697\u20131700","journal-title":"Hum Mol Genet"},{"key":"1035_CR32","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1471-4159.2008.05856.x","volume":"108","author":"X Li","year":"2009","unstructured":"Li X, Lu L, Bush DJ et al (2009) Mutant copper-zinc superoxide dismutase associated with amyotrophic lateral sclerosis binds to adenine\/uridine-rich stability elements in the vascular endothelial growth factor 3\u2032-untranslated region. J Neurochem 108:1032\u20131044","journal-title":"J Neurochem"},{"key":"1035_CR33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ana.21704","volume":"66","author":"HN Liu","year":"2009","unstructured":"Liu HN, Sanelli T, Horne P et al (2009) Lack of evidence of monomer\/misfolded superoxide dismutase-1 in sporadic amyotrophic lateral sclerosis. Ann Neurol 66:75\u201380","journal-title":"Ann Neurol"},{"key":"1035_CR34","doi-asserted-by":"crossref","first-page":"33989","DOI":"10.1074\/jbc.M109.067918","volume":"284","author":"L Lu","year":"2009","unstructured":"Lu L, Wang S, Zheng L et al (2009) Amyotrophic lateral sclerosis-linked mutant SOD1 sequesters Hu antigen R (HuR) and TIA-1-related protein (TIAR): implications for impaired post-transcriptional regulation of vascular endothelial growth factor. J Biol Chem 284:33989\u201333998","journal-title":"J Biol Chem"},{"key":"1035_CR35","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.1523\/JNEUROSCI.1877-07.2007","volume":"27","author":"L Lu","year":"2007","unstructured":"Lu L, Zheng L, Viera L et al (2007) Mutant Cu\/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression. J Neurosci 27:7929\u20137938","journal-title":"J Neurosci"},{"key":"1035_CR36","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.21147","volume":"61","author":"IR Mackenzie","year":"2007","unstructured":"Mackenzie IR, Bigio EH, Ince PG et al (2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 61:427\u2013434","journal-title":"Ann Neurol"},{"key":"1035_CR37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1474-4422(12)70043-1","volume":"11","author":"E Majounie","year":"2012","unstructured":"Majounie E, Renton AE, Mok K et al (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 11:323\u2013330","journal-title":"Lancet Neurol"},{"key":"1035_CR38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nature08971","volume":"465","author":"H Maruyama","year":"2010","unstructured":"Maruyama H, Morino H, Ito H et al (2010) Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465:223\u2013226","journal-title":"Nature"},{"key":"1035_CR39","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1046\/j.1471-4159.2002.01045.x","volume":"82","author":"FM Menzies","year":"2002","unstructured":"Menzies FM, Grierson AJ, Cookson MR et al (2002) Selective loss of neurofilament expression in Cu\/Zn superoxide dismutase (SOD1) linked amyotrophic lateral sclerosis. J Neurochem 82:1118\u20131128","journal-title":"J Neurochem"},{"key":"1035_CR40","first-page":"185","volume":"68","author":"A Migheli","year":"1993","unstructured":"Migheli A, Pezzulo T, Attanasio A, Schiffer D (1993) Peripherin immunoreactive structures in amyotrophic lateral sclerosis. Lab Invest 68:185\u2013191","journal-title":"Lab Invest"},{"key":"1035_CR41","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.bbadis.2006.03.001","volume":"1762","author":"K Moisse","year":"2006","unstructured":"Moisse K, Strong MJ (2006) Innate immunity in amyotrophic lateral sclerosis. Biochim Biophys Acta 1762:1083\u20131093","journal-title":"Biochim Biophys Acta"},{"key":"1035_CR42","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brainres.2008.10.021","volume":"1249","author":"K Moisse","year":"2009","unstructured":"Moisse K, Volkening K, Leystra-Lantz C et al (2009) Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy: implications for TDP-43 in the physiological response to neuronal injury. Brain Res 1249:202\u2013211","journal-title":"Brain Res"},{"key":"1035_CR43","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00401-004-0821-7","volume":"107","author":"T Nakano","year":"2004","unstructured":"Nakano T, Nakaso K, Nakashima K, Ohama E (2004) Expression of ubiquitin-binding protein p62 in ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis with dementia: analysis of five autopsy cases with broad clinicopathological spectrum. Acta Neuropathol 107:359\u2013364","journal-title":"Acta Neuropathol"},{"key":"1035_CR44","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130\u2013133","journal-title":"Science"},{"key":"1035_CR45","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1212\/WNL.0b013e31823a0cfc","volume":"77","author":"Y Okamoto","year":"2011","unstructured":"Okamoto Y, Ihara M, Urushitani M et al (2011) An autopsy case of SOD1-related ALS with TDP-43 positive inclusions. Neurology 77:1993\u20131995","journal-title":"Neurology"},{"key":"1035_CR46","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1440-1789.2011.01199.x","volume":"31","author":"T Osawa","year":"2011","unstructured":"Osawa T, Mizuno Y, Fujita Y et al (2011) Optineurin in neurodegenerative diseases. Neuropathology 31:569\u2013574","journal-title":"Neuropathology"},{"issue":"8","key":"1035_CR47","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrneurol.2012.117","volume":"8","author":"R Rademakers","year":"2012","unstructured":"Rademakers R, Neumann M, Mackenzie IR (2012) Advances in understanding the molecular basis of frontotemporal dementia. Nat Rev Neurol 8(8):423\u2013434","journal-title":"Nat Rev Neurol"},{"key":"1035_CR48","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","volume":"72","author":"AE Renton","year":"2011","unstructured":"Renton AE, Majounie E, Waite A et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72:257\u2013268","journal-title":"Neuron"},{"key":"1035_CR49","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neulet.2007.03.066","volume":"420","author":"J Robertson","year":"2007","unstructured":"Robertson J, Sanelli T, Xiao S et al (2007) Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS. Neurosci Lett 420:128\u2013132","journal-title":"Neurosci Lett"},{"key":"1035_CR50","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen DR, Siddique T, Patterson D et al (1993) Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59\u201362","journal-title":"Nature"},{"key":"1035_CR51","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00005072-199107000-00007","volume":"50","author":"D Schiffer","year":"1991","unstructured":"Schiffer D, Autilio-Gambetti L, Chio A et al (1991) Ubiquitin in motor neuron disease: study at the light and electron microscope. J Neuropathol Exp Neurol 50:463\u2013473","journal-title":"J Neuropathol Exp Neurol"},{"key":"1035_CR52","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1159\/000111445","volume":"18","author":"N Shibata","year":"1996","unstructured":"Shibata N, Asayama K, Hirano A, Kobayashi M (1996) Immunohistochemical study on superoxide dismutases in spinal cords from autopsied patients with amyotrophic lateral sclerosis. Dev Neurosci 18:492\u2013498","journal-title":"Dev Neurosci"},{"key":"1035_CR53","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/BF02976748","volume":"21","author":"J Shin","year":"1998","unstructured":"Shin J (1998) P62 and the sequestosome, a novel mechanism for protein metabolism. Arch Pharm Res 21:629\u2013633","journal-title":"Arch Pharm Res"},{"key":"1035_CR54","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/01.wnl.0000289191.54852.75","volume":"71","author":"K Sleegers","year":"2008","unstructured":"Sleegers K, Brouwers N, Maurer-Stroh S et al (2008) Progranulin genetic variability contributes to amyotrophic lateral sclerosis. Neurology 71:253\u2013259","journal-title":"Neurology"},{"key":"1035_CR55","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0163-7258(03)00040-8","volume":"98","author":"MJ Strong","year":"2003","unstructured":"Strong MJ (2003) The basic aspects of therapeutics in amyotrophic lateral sclerosis. Pharmacol Ther 98:379\u2013414","journal-title":"Pharmacol Ther"},{"key":"1035_CR56","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/17482960802372371","volume":"9","author":"MJ Strong","year":"2008","unstructured":"Strong MJ (2008) The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 9:323\u2013338","journal-title":"Amyotroph Lateral Scler"},{"key":"1035_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2009.09.029","volume":"288","author":"MJ Strong","year":"2010","unstructured":"Strong MJ (2010) The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS). J Neurol Sci 288:1\u201312","journal-title":"J Neurol Sci"},{"key":"1035_CR58","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/17482960802654364","volume":"10","author":"MJ Strong","year":"2009","unstructured":"Strong MJ, Grace GM, Freedman M et al (2009) Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10:131\u2013146","journal-title":"Amyotroph Lateral Scler"},{"key":"1035_CR59","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.jnen.0000173889.71434.ea","volume":"64","author":"MJ Strong","year":"2005","unstructured":"Strong MJ, Kesavapany S, Pant HC (2005) The pathobiology of amyotrophic lateral sclerosis: a proteinopathy? J Neuropathol Exp Neurol 64:649\u2013664","journal-title":"J Neuropathol Exp Neurol"},{"key":"1035_CR60","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.mcn.2007.03.007","volume":"35","author":"MJ Strong","year":"2007","unstructured":"Strong MJ, Volkening K, Hammond R et al (2007) TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol Cell Neurosci 35:320\u2013327","journal-title":"Mol Cell Neurosci"},{"key":"1035_CR61","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/NEN.0b013e3181919cb5","volume":"68","author":"H Sumi","year":"2009","unstructured":"Sumi H, Kato S, Mochimaru Y et al (2009) Nuclear TAR DNA binding protein 43 expression in spinal cord neurons correlates with the clinical course in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 68:37\u201347","journal-title":"J Neuropathol Exp Neurol"},{"key":"1035_CR62","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1634\/stemcells.2007-0283","volume":"26","author":"B Thyagarajan","year":"2008","unstructured":"Thyagarajan B, Liu Y, Shin S et al (2008) Creation of engineered human embryonic stem cell lines using phiC31 integrase. Stem Cells 26:119\u2013126","journal-title":"Stem Cells"},{"key":"1035_CR63","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1128\/MCB.21.12.3926-3934.2001","volume":"21","author":"B Thyagarajan","year":"2001","unstructured":"Thyagarajan B, Olivares EC, Hollis RP, Ginsburg DS, Calos MP (2001) Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase. Mol Cell Biol 21:3926\u20133934","journal-title":"Mol Cell Biol"},{"key":"1035_CR64","doi-asserted-by":"crossref","first-page":"20235","DOI":"10.1074\/jbc.271.34.20235","volume":"271","author":"RK Vadlamudi","year":"1996","unstructured":"Vadlamudi RK, Joung I, Strominger JL, Shin J (1996) p62, a phosphotyrosine-independent ligand of the SH2 domain of p56lck, belongs to a new class of ubiquitin-binding proteins. J Biol Chem 271:20235\u201320237","journal-title":"J Biol Chem"},{"key":"1035_CR65","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1212\/WNL.0b013e31821f445b","volume":"76","author":"P Damme Van","year":"2011","unstructured":"Van Damme P, Veldink JH, van Blitterswijk M et al (2011) Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2. Neurology 76:2066\u20132072","journal-title":"Neurology"},{"key":"1035_CR66","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.1165942","volume":"323","author":"C Vance","year":"2009","unstructured":"Vance C, Rogelj B, Hortobagyi T et al (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323:1208\u20131211","journal-title":"Science"},{"key":"1035_CR67","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/17482960902995584","volume":"11","author":"K Volkening","year":"2010","unstructured":"Volkening K, Leystra-Lantz C, Strong MJ (2010) Human low molecular weight neurofilament (NFL) mRNA interacts with a predicted p190RhoGEF homologue (RGNEF) in humans. Amyotroph Lateral Scler 11:97\u2013103","journal-title":"Amyotroph Lateral Scler"},{"key":"1035_CR68","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/jnen\/59.11.972","volume":"59","author":"NK Wong","year":"2000","unstructured":"Wong NK, He BP, Strong MJ (2000) Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS). J Neuropathol Exp Neurol 59:972\u2013982","journal-title":"J Neuropathol Exp Neurol"},{"key":"1035_CR69","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1073\/pnas.0510611103","volume":"103","author":"J Zielinski","year":"2006","unstructured":"Zielinski J, Kilk K, Peritz T et al (2006) In vivo identification of ribonucleoprotein-RNA interactions. Proc Natl Acad Sci USA 103:1557\u20131562","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-012-1035-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-012-1035-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-012-1035-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T04:35:54Z","timestamp":1562128554000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-012-1035-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,1]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["1035"],"URL":"https:\/\/doi.org\/10.1007\/s00401-012-1035-z","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,1]]}}}